Early studies suggest potential benefits in conditions involving impaired intestinal motility or altered gut hormone signaling, including metabolic disorders and certain gastrointestinal diseases
Batch: GF-DSIP5-B241 Key analytical results include: Assay Content: 5.51 mg Identification Retention Time: 0.991 Identification FTIR Spectrum: 994 Molecular Ion Mass Identification: 848 Da Purity: 99.8 percent Bacterial Endotoxins: 0.020 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Product Overview DSIP, short for Delta Sleep-Inducing Peptide, is a synthetic peptide research compound studied in controlled laboratory environments focused on neuropeptide signalling pathways, peptide-mediated communication systems and molecular regulatory mechanisms
H.MonsieursP.ImamuraH.MaesI.KukN.YagoubatA.et al (2022)
Banerjee, P.G
I usually explain that results are gradual, reversible, and depend on the route, skin type, pigmentation pattern, lifestyle, and consistency
Beyond this threshold, it becomes impossible to determine which compounds provide benefits versus side effects, making adjustments nearly impossible
